Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 2/20 | 0.37 |
| ▸ | HTR2B | P41595 | 2/20 | 0.37 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18242518 | 0.81 | PNMT (0.43) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL30089730 | 0.81 | PNMT (0.47) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL24262482 | 0.80 | SETD7 (0.34) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL22263591 | 0.80 | PNMT (0.57) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL29090328 | 0.79 | PNMT (0.46) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL4359047 | 0.79 | PNMT (0.53) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL6555945 | 0.78 | PNMT (0.41) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL28568070 | 0.78 | PNMT (0.52) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL9125626 | 0.76 | PGR (0.42) | PNMTNPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL524602 | 0.75 | PNMT (0.63) | PNMTNPC1RAB9AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250120252-A1 | MATERIALS FOR FORMING A NUCLEATION-INHIBITING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2025-04-10 | — | — | US | claimed |
| US-12178064-B2 | Materials for forming a nucleation-inhibiting coating and devices incorporating same | OTI LUMIONICS INC. (CA) | 2024-12-24 | — | — | US | claimed |
| US-12069939-B2 | Method for patterning a coating on a surface and device including a patterned coating | OTI LUMIONICS INC. (CA) | 2024-08-20 | — | — | US | claimed |
| US-20230363196-A1 | MATERIALS FOR FORMING A NUCLEATION-INHIBITING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2023-11-09 | — | — | US | claimed |
| CN-116583131-A | Method for patterning a surface coating and apparatus comprising a patterned coating | OTI照明公司 | 2023-08-11 | — | — | CN | claimed |
| US-20230165124-A1 | METHOD FOR PATTERNING A COATING ON A SURFACE AND DEVICE INCLUDING A PATTERNED COATING | OTI LUMIONICS INC. (CA) | 2023-05-25 | — | — | US | claimed |
| US-11581487-B2 | Patterned conductive coating for surface of an opto-electronic device | OTI LUMIONICS INC. (CA) | 2023-02-14 | — | — | US | claimed |
| US-12590244-B2 | Method for patterning a coating on a surface and device including a patterned coating | OTI LUMIONICS INC. (CA) | 2026-03-31 | — | — | US | disclosed |
| US-20250120252-A1 | MATERIALS FOR FORMING A NUCLEATION-INHIBITING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2025-04-10 | — | — | US | disclosed |
| US-20250024700-A1 | DEVICE INCLUDING A CONDUCTIVE COATING DISPOSED OVER EMISSIVE REGIONS AND METHOD THEREFOR | OTI Lumonics Inc. (CA) | 2025-01-16 | — | — | US | disclosed |
| US-12178064-B2 | Materials for forming a nucleation-inhibiting coating and devices incorporating same | OTI LUMIONICS INC. (CA) | 2024-12-24 | — | — | US | disclosed |
| US-12150374-B2 | Method for patterning a coating on a surface and device including a patterned coating | OTI LUMIONICS INC. (CA) | 2024-11-19 | — | — | US | disclosed |
| US-20240381754-A1 | METHOD FOR PATTERNING A COATING ON A SURFACE AND DEVICE INCLUDING A PATTERNED COATING | OTI LUMIONICS INC. (CA) | 2024-11-14 | — | — | US | disclosed |
| US-4540700-A | Treatment of diabetic complications with certain spiro-imidazolidine-diones | ALCON LABORATORIES, INC. (US) | 1985-09-10 | — | — | US | disclosed |
| US-4438272-A | COMPLICATIONS OF DIABETES | ALCON LABORATORIES, INC. (US) | 1984-03-20 | — | — | US | disclosed |
| US-4436745-A | TETRACYCLIC SPIROHYDANTOINS | ALCON LABORATORIES, INC. (US) | 1984-03-13 | — | — | US | disclosed |
| WO-1983003543-A1 | METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS | ALCON LAB INC (US) | 1983-10-27 | — | — | WO | disclosed |
| WO-1983003543-A1 | METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS | ALCON LAB INC (US) | 1983-10-27 | — | — | WO | disclosed |
| EP-0092385-A2 | Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds | ALCON LABORATORIES, INC. (US) | 1983-10-26 | — | — | EP | disclosed |
| EP-0092385-A2 | Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds | ALCON LABORATORIES, INC. (US) | 1983-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590244-B2 | Method for patterning a coating on a surface and device including a patterned coating | FLNB, FZD7, ITGB6 | PNMT 2442/4885NPC1 714/4885RAB9A 1827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.